Dynamic Contrast-Enhanced MRI in the Liver

  • Alan Jackson
  • David A. Nicholson
Part of the Medical Radiology book series (MEDRAD)


Magn Reson Image Focal Nodular Hyperplasia Dynamic Magnetic Resonance Image Focal Liver Lesion Dynamic Contrast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229:409–414PubMedGoogle Scholar
  2. Asahina Y, Izumi N, Uchihara M, Noguchi O, Ueda K, Inoue K, Nishimura Y, Tsuchiya K, Hamano K, Itakura J, Himeno Y, Koike M, Miyake S (2003) Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography. Hepatol Res 27:196–204CrossRefPubMedGoogle Scholar
  3. Bartolozzi C, Lencioni R, Donati F, Cioni D (1999) Abdominal MR: liver and pancreas. Eur Radiol 9:1496–1512PubMedGoogle Scholar
  4. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421–430CrossRefPubMedGoogle Scholar
  5. Carlos RC, Branam JD, Dong Q, Hussain HK, Francis IR (2002) Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient. Acad Radiol 9:1322–1325CrossRefPubMedGoogle Scholar
  6. Carlson SK, Johnson CD, Bender CE, Welch TJ (2000) CT of focal nodular hyperplasia of the liver. AJR Am J Roentgenol 174(3):705–712PubMedGoogle Scholar
  7. Catasca JV, Mirowitz SA (1994) T2-weighted MR imaging of the abdomen: fast spin-echo vs conventional spin-echo sequences. AJR Am J Roentgenol 162(1):61–67PubMedGoogle Scholar
  8. Choi CS, Freeny PC (1998) Triphasic helical CT of hepatic focal nodular hyperplasia: incidence of atypical findings. AJR Am J Roentgenol 170:391–395PubMedGoogle Scholar
  9. Coffin CM, Diche T, Mahfouz A, Alexandre M, Caseiro-Alves F, Rahmouni A, Vasile N, Mathieu D (1999) Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 9:444–449CrossRefPubMedGoogle Scholar
  10. del Frate C, Bazzocchi M, Mortele KJ, Zuiani C, Londero V, Como G, Zanardi R, Ros PR (2002) Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology 225:766–772PubMedGoogle Scholar
  11. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7(3):462–503PubMedGoogle Scholar
  12. Fretz CJ, Elizondo G, Weissleder R, Hahn PF, Stark DD, Ferrucci JT (1989) Superparamagnetic iron oxide-enhanced MR imaging: pulse sequence optimization for detection of liver cancer. Radiology 172:393–397PubMedGoogle Scholar
  13. Fretz CJ, Stark DD, Metz CE, Elizondo G, Weissleder R, Shen JH, Wittenberg J, Simeone J, Ferrucci JT (1990) Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. AJR Am J Roentgenol 155:763–770PubMedGoogle Scholar
  14. Grazioli L, Olivetti L, Fugazzola C, Benetti A, Stanga C, Dettori E, Gallo C, Matricardi L, Giacobbe A, Chiesa A (1999) The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 9:62–67PubMedGoogle Scholar
  15. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A (2001) Hepatic adenomas: imaging and pathologic findings. Radiographics 21:877–92; discussion 892–4PubMedGoogle Scholar
  16. Hanafusa K, Ohashi I, Himeno Y, Suzuki S, Shibuya H (1995) Hepatic hemangioma: findings with two-phase CT. Radiology 196:465–469PubMedGoogle Scholar
  17. Hanafusa K, Ohashi I, Gomi N, Himeno Y, Wakita T, Shibuya H (1997) Differential diagnosis of early homogeneously enhancing hepatocellular carcinoma and hemangioma by two-phase CT. J Comput Assist Tomogr 21:361–368CrossRefPubMedGoogle Scholar
  18. Hussain HK, Londy FJ, Francis IR, Nghiem HV, Weadock WJ, Gebremariam A, Chenevert TL (2003) Hepatic arterial phase MR imaging with automated bolus-detection three-dimensional fast gradient-recalled-echo sequence: comparison with test-bolus method. Radiology 226:558–566PubMedGoogle Scholar
  19. Ichikawa T, Federle MP, Grazioli L, Nalesnik M (2000) Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214:861–868PubMedGoogle Scholar
  20. Jackson A, Haroon H, Zhu XP, Li KL, Thacker NA, Jayson G (2002) Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model. NMR Biomed 15(2):164–173CrossRefPubMedGoogle Scholar
  21. Jayson GC, Zweit J, Jackson A, Mulatero C, Julyan P, Ranson M, Broughton L, Wagstaff J, Hakannson L, Groenewegen G, Bailey J, Smith N, Hastings D, Lawrance J, Haroon H, Ward T, McGown AT, Tang M, Levitt D, Marreaud S, Lehmann FF, Herold M, Zwierzina H (2002) Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst 94:1484–1493PubMedGoogle Scholar
  22. Jeong MG, Yu JS, Kim KW, Jo BJ, Kim JK (1999) Early homogeneously enhancing hemangioma versus hepatocellular carcinoma: differentiation using quantitative analysis of multiphasic dynamic magnetic resonance imaging. Yonsei Med J 40:248–255PubMedGoogle Scholar
  23. Kanematsu M, Semelka RC, Matsuo M, Kondo H, Enya M, Goshima S, Moriyama N, Hoshi H (2002) Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases—a prospective randomized study in patients with chronic liver damage. Radiology 225:407–415PubMedGoogle Scholar
  24. Kapoor V, Peterson MS, Baron RL, Patel S, Eghtesad B, Fung JJ (2002) Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. AJR Am J Roentgenol 179:1281–1286PubMedGoogle Scholar
  25. King LJ, Burkill GJ, Scurr ED, Vlavianos P, Murray-Lyons I, Healy JC (2002) MnDPDP enhanced magnetic resonance imaging of focal liver lesions. Clin Radiol 57:1047–1057CrossRefPubMedGoogle Scholar
  26. Kirchin MA, Spinazzi A (2002) Low-dose gadobenate dimeglumine-enhanced MRI in the detection and characterization of focal liver lesions. Acad Radiol 9Suppl 1:S121–126PubMedGoogle Scholar
  27. Lavelle MT, Lee VS, Rofsky NM, Krinsky GA, Weinreb JC (2001) Dynamic contrast-enhanced three-dimensional MR imaging of liver parenchyma: source images and angiographic reconstructions to define hepatic arterial anatomy. Radiology 218(2):389–394PubMedGoogle Scholar
  28. Li KL, Zhu XP, Waterton J, Jackson A (2000) Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 12:347–357CrossRefPubMedGoogle Scholar
  29. Li KL, Zhu XP, Checkley DR, Tessier JJ, Hillier VF, Waterton JC, Jackson A (2003) Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 76:39–50CrossRefPubMedGoogle Scholar
  30. Lim JH, Choi D, Cho SK, Kim SH, Lee WJ, Lim HK, Park CK, Paik SW, Kim YI (2001) Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 220:669–676PubMedGoogle Scholar
  31. Manfredi R, Maresca G, Baron RL, Cotroneo AR, De Gaetano AM, De Franco A, Pirovano G, Spinazzi A, Marano P (1999) Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA). J Magn Reson Imaging 9:704–710CrossRefPubMedGoogle Scholar
  32. Materne R, Horsmans Y, Jamart J, Smith AM, Gigot JF, Van Beers BE (2000) Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients. J Magn Reson Imaging 11:244–249CrossRefPubMedGoogle Scholar
  33. Materne R, Van Beers BE, Smith AM, Leconte I, Jamart J, Dehoux JP, Keyeux A, Horsmans Y (2000) Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 99:517–525CrossRefPubMedGoogle Scholar
  34. Materne R, Annet L, Dechambre S, Sempoux C, Smith AM, Corot C, Horsmans Y, Van Beers BE (2002) Dynamic computed tomography with low-and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis. Clin Sci (Lond) 103:213–216PubMedGoogle Scholar
  35. Materne R, Smith AM, Peeters F, Dehoux JP, Keyeux A, Horsmans Y, Van Beers BE (2002) Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 47:135–142CrossRefPubMedGoogle Scholar
  36. Mitchell DG, Saini S, Weinreb J, De Lange EE, Runge VM, Kuhlman JE, Parisky Y, Johnson CD, Brown JJ, Schnall M et al (1994) Hepatic metastases and cavernous hemangiomas: distinction with standard-and triple-dose gadoteridol-enhanced MR imaging. Radiology 193:49–57PubMedGoogle Scholar
  37. Morana G, Grazioli L, Schneider G, Testoni M, Menni K, Chiesa A, Procacci C (2002) Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA. Acad Radiol 9Suppl 2:S476–479CrossRefPubMedGoogle Scholar
  38. Morana G, Grazioli L, Testoni M, Caccia P, Procacci C (2002) Contrast agents for hepatic magnetic resonance imaging. Top Magn Reson Imaging 13:117–150CrossRefPubMedGoogle Scholar
  39. Morgan B, Thomas AL, Drevs J, Hennig J, Buchert M, Jivan A, Horsfield MA, Mross K, Ball HA, Lee L, Mietlowski W, Fuxuis S, Unger C, O'Byrne K, Henry A, Cherryman GR, Laurent D, Dugan M, Marmé D, Steward WP (2003) Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 21:3955–3964CrossRefPubMedGoogle Scholar
  40. Murakami T, Baron RL, Peterson MS, Oliver JH 3rd, Davis PL, Confer SR, Federle MP (1996) Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 200(1):69–77PubMedGoogle Scholar
  41. Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23:1441–1454CrossRefPubMedGoogle Scholar
  42. Noguchi Y, Murakami T, Kim T, Hori M, Osuga K, Kawata S, Kumano S, Okada A, Sugiura T, Nakamura H (2003) Detection of hepatocellular carcinoma: comparison of dynamic MR imaging with dynamic double arterial phase helical CT. AJR Am J Roentgenol 180:455–460PubMedGoogle Scholar
  43. Padovani B, Lecesne R, Raffaelli C, Chevallier P, Drouillard J, Bruneton JN, Lambrechts M, Gordon P (1996) Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique. Eur J Radiol 23:205–211CrossRefPubMedGoogle Scholar
  44. Pena CS, Saini S, Baron RL, Hamm BA, Morana G, Caudana R, Giovagnoni A, Villa A, Carriero A, Mathieu D, Bourne MW, Kirchin MA, Pirovano G, Spinazzi A (2001) Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial. Korean J Radiol 2(4):210–215PubMedGoogle Scholar
  45. Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R, Bartolozzi C, Grazioli L, Chiesa A, Manfredi R, Marano P, Van Persijn Van Meerten EL, Bloem JL, Petre C, Marchal G, Greco A, McNamara MT, Heuck A, Reiser M, Laniado M, Claussen C, Daldrup HE, Rummeny E, Kirchin MA, Pirovano G, Hamm B (2000) Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging—a multicenter phase III clinical study. Radiology 215:727–736Google Scholar
  46. Pirovano G, Vanzulli A, Marti-Bonmati L, Grazioli L, Manfredi R, Greco A, Holzknecht N, Daldrup-Link HE, Rummeny E, Hamm B, Arneson V, Imperatori L, Kirchin MA, Spinazzi A (2000) Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR Am J Roentgenol 175:1111–1120PubMedGoogle Scholar
  47. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedGoogle Scholar
  48. Reinig JW (1995) Breath-hold fast spin-echo MR imaging of the liver: a technique for high-quality T2-weighted images. Radiology 194(2):303–304PubMedGoogle Scholar
  49. Rofsky NM, Earls JP (1996) Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging. Magn Reson Imaging Clin N Am 4(1):73–85PubMedGoogle Scholar
  50. Rummeny EJ, Marchal G (1997) Liver imaging. Clinical applications and future perspectives. Acta Radiol 38(4 Pt 2):626–630PubMedGoogle Scholar
  51. Scharf J, Zapletal C, Hess T, Hoffmann U, Mehrabi A, Mihm D, Hoffmann V, Brix G, Kraus T, Richter GM, Klar E (1999) Assessment of hepatic perfusion in pigs by pharmacokinetic analysis of dynamic MR images. J Magn Reson Imaging 9:568–572PubMedGoogle Scholar
  52. Schima W, Petersein J, Hahn PF, Harisinghani M, Halpern E, Saini S (1997) Contrast-enhanced MR imaging of the liver: comparison between Gd-BOPTA and Mangafodipir. J Magn Reson Imaging 7:130–135PubMedGoogle Scholar
  53. Schima W, Saini S, Petersein J, Weissleder R, Harisinghani M, Mayo-Smith W, Hahn PF (1999) MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses. J Magn Reson Imaging 10:80–83PubMedGoogle Scholar
  54. Schmitz SA, Wagner S, Schuhmann-Giampieri G, Krause W, Bollow M, Wolf KJ (1997) Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs. Radiology 205:361–366PubMedGoogle Scholar
  55. Schmitz SA, Wagner S, Schuhmann-Giampieri G, Krause W, Wolf KJ (1997) A prototype liver-specific contrast medium for CT: preclinical evaluation of gadoxetic acid disodium, or Gd-EOB-DTPA. Radiology 202:407–412PubMedGoogle Scholar
  56. Schuhmann-Giampieri G, Mahler M, Roll G, Maibauer R, Schmitz S (1997) Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans. J Clin Pharmacol 37(7):587–596PubMedGoogle Scholar
  57. Semelka RC, Shoenut JP, Ascher SM, Kroeker MA, Greenberg HM, Yaffe CS, Micflikier AB (1994) Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences. J Magn Reson Imaging 4(3):319–323PubMedGoogle Scholar
  58. Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13:397–401CrossRefPubMedGoogle Scholar
  59. Siewert B, Müller MF, Foley M, Wielopolski PA, Finn JP (1994) Fast MR imaging of the liver: quantitative comparison of techniques. Radiology 193:37–42PubMedGoogle Scholar
  60. Spinazzi A, Lorusso V, Pirovano G, Kirchin M (1999) Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 6:282–291PubMedGoogle Scholar
  61. Spritzer CE, Keogan MT, DeLong DM, Dahlke J, MacFall JR (1996) Optimizing fast spin echo acquisitions for hepatic imaging in normal subjects. J Magn Reson Imaging 6:128–135PubMedGoogle Scholar
  62. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT (1988) Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168:297–301PubMedGoogle Scholar
  63. Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M (1996) Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 24:807–812PubMedGoogle Scholar
  64. Van Beers BE, Gallez B, Pringot J (1997) Contrast-enhanced MR imaging of the liver. Radiology 203(2):297–306PubMedGoogle Scholar
  65. Van Beers BE, Materne R, Lacrosse M, Jamart J, Smith AM, Horsmans Y, Gigot JF, Gilon R, Pringot J (1999) MR imaging of hypervascular liver tumors: timing optimization during the arterial phase. J Magn Reson Imaging 9:562–567CrossRefPubMedGoogle Scholar
  66. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y (2001) Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 176:667–673PubMedGoogle Scholar
  67. van Laarhoven HW, Rijpkema M, Punt CJ, Ruers TJ, Hendriks JC, Barentsz JO, Heerschap A (2003) Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases. J Magn Reson Imaging 18:315–320CrossRefPubMedGoogle Scholar
  68. Vitellas KM, El-Dieb A, Vaswani KK, Bennett WF, Fromkes J, Ellison C, Bova JG (2002) Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients. AJR Am J Roentgenol 179:409–416PubMedGoogle Scholar
  69. Vitellas KM, Enns RA, Keogan MT, Freed KS, Spritzer CE, Baillie J, Nelson RC (2002) Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis. AJR Am J Roentgenol 178:327–334PubMedGoogle Scholar
  70. Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, Schwarz W, Müller PK, Bechstein WO, Mack MG, Söllner O, Felix R (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–67PubMedGoogle Scholar
  71. Wang C, Ahlström H, Ekholm S, Fagertun H, Hellström M, Hemmingsson A, Holtåas S, Isberg B, Jonnson E, Lönnemark-Magnusson M, McGill S, Wallengren NO, Westman L (1997) Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study. Acta Radiol 38:643–649PubMedGoogle Scholar
  72. Wanless IR (1996) Nodular regenerative hyperplasia, dysplasia, and hepatocellular carcinoma. Am J Gastroenterol 91:836–837PubMedGoogle Scholar
  73. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 152:167–173PubMedGoogle Scholar
  74. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L (1990) Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 175:489–493PubMedGoogle Scholar
  75. Whitney WS, Herfkens RJ, Jeffrey RB, McDonnell CH, Li KC, Van Dalsem WJ, Low RN, Francis IR, Dabatin JF, Glazer GM (1993) Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1. 5 T. Radiology 189:863–870PubMedGoogle Scholar
  76. Yamashita Y, Fan ZM, Yamamoto H, Matsukawa T, Yoshimatsu S, Miyazaki T, Sumi M, Harada M, Takahashi M (1994) Spin-echo and dynamic gadolinium-enhanced FLASH MR imaging of hepatocellular carcinoma: correlation with histopathologic findings. J Magn Reson Imaging 4:83–90PubMedGoogle Scholar
  77. Yoshioka H, Takahashi N, Yamaguchi M, Lou D, Saida Y, Itai Y (2002) Double arterial phase dynamic MRI with sensitivity encoding (SENSE) for hypervascular hepatocellular carcinomas. J Magn Reson Imaging 16:259–266CrossRefPubMedGoogle Scholar
  78. Yu JS, Kim KW, Jo BJ, Jeong MG, Kim JK, Hahm JK, Lee JT, Yoo HS (2000) Test-bolus injection for optimization of arterial phase imaging during contrast-enhanced hepatic MR imaging. Yonsei Med J 41:459–467PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Alan Jackson
    • 1
  • David A. Nicholson
    • 2
  1. 1.Imaging Science and Biomedical Engineering, The Medical SchoolUniversity of ManchesterManchesterUK
  2. 2.Hope HospitalSalfordUK

Personalised recommendations